CD44 and ovarian cancer: Studies evaluating gene expression in embryo implantation, endometriosis and ovarian cancer [10,40,41,63] have all found altered expression of LIF, and other genetic and epigenetic changes, such as CD44 and miR 99a-5p [42,43], supporting our hypothesis that the uterine secretome is important in all these processes.